News
Surovatamig shows promise, but needs to outperform established therapies such as Blincyto and Aucatzyl.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback